Related Experiment Video
Updated: Jan 17, 2026
06:16
Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models
Published on: March 16, 2022
3.6K
Update on Gene Therapy Clinical Trials for Eye Diseases.
Nicolas Lonfat1, Laura Moreno-Leon1, Claudio Punzo2
1Astellas Pharma Inc., Westborough, Massachusetts, USA.
Human Gene Therapy
|September 18, 2025
Summary
Gene therapy offers promising new treatments for inherited retinal diseases like retinitis pigmentosa and macular degeneration. Current clinical trials show potential for gene-specific and gene-agnostic approaches to restore vision and combat blindness.
Area of Science:
- Ophthalmology and Genetics
- Retinal Degenerative Diseases
- Gene Therapy Applications
Background:
- Inherited and complex retinal diseases cause significant irreversible vision loss globally.
- Genetic heterogeneity and complex mechanisms impede effective disease-modifying treatments.
- Current therapeutic options for conditions like retinitis pigmentosa, age-related macular degeneration, and glaucoma are limited.
Purpose of the Study:
- To review current gene therapeutic strategies for treating blinding retinal conditions.
- To provide an update on ongoing and completed clinical trials for retinal gene therapy.
- To discuss the efficacy and delivery methods of novel gene-based treatments.
Main Methods:
- Review of clinical trials focusing on gene-specific and gene-agnostic gene therapy approaches.
- Analysis of recombinant adeno-associated viral vector (AAV)-mediated gene delivery methods.
- Evaluation of gene editing technologies and antisense oligonucleotide applications in ocular therapy.
- Assessment of ocular delivery routes: subretinal, intravitreal, and suprachoroidal.
Main Results:
- Initial clinical trial data indicate the feasibility of various gene therapy delivery methods.
- Recombinant AAV vectors are being utilized for delivering full genes or gene-editing components.
- Early results suggest potential efficacy across different ocular delivery strategies.
Conclusions:
- Gene therapy demonstrates significant potential to revolutionize the management of retinal diseases.
- Further long-term clinical data and refined endpoints are necessary to confirm efficacy, safety, and durability.
- Gene therapy represents a promising avenue for patients suffering from debilitating retinal conditions.
Related Concept Videos
00:59Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
01:27Open Angle Glaucoma: Treatment
963
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
963
01:28Angle Closure Glaucoma: Treatment
1.2K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K
01:16Clinical Trials
10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.2K
01:11Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
01:25Glaucoma: Overview
1.3K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.3K